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Abstract: Although soybean isoflavones naturally accumulate in their conjugated 
forms, the beneficial effects on human health of soybean-containing foods have 
been credited to their aglycone forms. In the present study we analyzed the effects 
of a chemical agent, sodium nitroprusside (SNP), in eliciting the exudation of non-
conjugated isoflavones from intact soybean seeds, embrionary axes and cotyledons. 
The isoflavones in the exudates were determined by high performance liquid 
chromatography and mass spectrometry. The effect of the exudates on the emission 
of nitric oxide (NO) and on the proliferation of breast carcinoma cells (MCF-7) 
was also evaluated. SNP elicitation increased the production of the aglycone forms 
dose- and time-dependently. Exudates of embrionary axes and cotyledons stimulated 
NO emission and showed biphasic effects on viability of MCF-7 cells. At lower 
concentrations both extracts presented proliferative effects (10-25%), and at higher 
concentrations inhibited (15%) cell proliferation. The biphasic effect might be due 
to the action of isoflavone aglycones in activating estrogen receptors which in turn 
stimulate the production of NO. Overall, the results suggest that soybean extracts 
enriched in isoflavone aglycones by elicitation with SNP could be exploited as a 
functional ingredient in the food industry.
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Introduction
 The potential of functional foods to provide 
health benefi ts has been increasingly recognized. 
Epidemiological evidence has supported the proposal 
that isofl avones are the agents in soybean which account 
for the apparent association between the increase in soy 
consumption and the reduction in the incidence of various 
chronic diseases (Adlercreutz & Mazur, 1997; Brouns, 
2002). Several reports have described the positive effect 
of isofl avones on the prevention of hormone-dependent 
cancers, cardiovascular diseases, osteoporosis, adverse 
menopausal manifestations and accelerated cognitive 
decline (Pilšáková et al., 2010). Other studies have 
demonstrated a signifi cant correlation between the 
consumption of isofl avonoid-rich foods by people in East 
Asia and a lower incidence of breast, prostate and large 
intestine carcinomas and cardiovascular disease, the so-
called “diseases of western countries” (Adlercreutz & 
Mazur, 1997). 
 Isofl avones are found as aglycones, β-glucosides 
and β-glucosides conjugated with malonyl and acetyl 
acids in nature. Although predominantly found in their 
conjugated forms (Liu, 1997), several evidences indicate 
that the free forms of soybean-derived isofl avones (the 
aglycones daidzein, glycitein and genistein) exhibit the 
highest biological activities (Brown & Setchell, 2001). 
These activities have been attributed to their antioxidant 
action (Yen & Lai, 2003) and structural similarity to the 
estradiol hormone (Pilšáková et al., 2010). There are 
claims that, acting as estradiol, isofl avones aglycones 
may modulate immunological responses, cancer 
proliferation and prevent cardiovascular diseases and 
osteoporosis (Messina & Messina, 1991; Brouns, 2002; 
Taku et al., 2011). At least part of these effects is due 
to nitric oxide synthase (NOS) modulation by estradiol 
Article
Soybean extracts enriched with free isoflavones promote nitric oxide 
synthesis and affect the proliferation of breast adenocarcinoma cells
Pablo G. Ferreira et al.
Rev. Bras. Farmacogn. Braz. J. Pharmacogn. 23(1): Jan./Feb. 2013 87
(Townsend et al., 2011). In cancer, at low concentrations, 
NO is proangiogenic and may promote tumor growth; 
however, at higher concentrations, NO can be cytostatic 
and cytotoxic, thus inhibiting tumor growth (Jenkins et 
al., 1995).
 Despite the controversial data concerning the 
bioavailability of isoflavones, it is accepted that only 
aglycones forms are absorbed in the stomach (Piskula et 
al., 1999), and are absorbed faster and in greater amounts 
than their glucoside forms in the intestine (Izumi et 
al., 2000). In fact, isoflavone absorption was shown to 
require initial hydrolysis by intestinal β-glucosidases 
(Setchell et al., 2002). These observations suggest 
that biotechnological and biochemical processes that 
would induce the production of aglycones may provide 
both nutritional and economic benefits in diseases 
prevention. 
 Soybean isoflavones are synthesized as a 
branch of the phenylpropanoid pathway, a secondary 
biosynthetic route in plants that can be activated in 
response to a variety of biotic and abiotic stresses (Dixon 
et al., 2002). Nitric oxide has been identified as a key 
activator of this pathway by inducing transcriptional 
activation of genes encoding key enzymes in this 
route, such as phenylalanine ammonia lyase (PAL) 
and chalcone synthase (Delledonne et al., 1998). In 
soybean cotyledons the NO donor sodium nitroprusside 
(SNP) was shown to induce large accumulation of 
free isoflavones (Modolo et al., 2002). This response 
was suggested to result from the stimulatory effect of 
SNP on the activity of PAL and, additionally, on the 
B-glicosidases, resulting in the release of pre-formed 
isoflavone conjugates (Kretzchmar et al., 2009). Taking 
into account these previous observations, in this study 
we present an improved technique to increase the yield 
of free isoflavones in soybean seeds using the NO donor 
molecule SNP, and evaluate the effects of the exudates 
produced in the proliferation of breast adenocarcinoma 
cells via NO production.
Material and Methods
Plant material
 Soybean seeds [Glycine max (L.) Merril 
cv. IAC-18] were provided by Dr. Nelson R. Braga 
(Instituto Agronômico de Campinas, Campinas, São 
Paulo, Brazil) and kept at 4 °C until analysis. 
Elicitation assay and exudates preparation
 Soybean seeds were sterilized with sodium 
hypochlorite 0.3%, seed coats were removed and 
detached embrionary axes or cotyledons (50 units/10 
mL) were treated with an aqueous solution of sodium 
nitroprusside (SNP) at several concentrations and for 
different periods of time, as indicated in the figure 
legends. After the elicitation time, the samples were 
filtered and the exudate mixed with 10 mL methanol 
80%. They were then extracted for 20 min on a rotary 
mixer model NT150 (Nova Técnica, Piracicaba, Brazil), 
dried, solubilized in 500 μL of methanol/formic acid 
5% (1:1) and filtered through a 0.22 μm Millipore 
membrane (Billerica, MA)  prior to HPLC analysis.
Determination of conjugated and aglycone isoflavones 
 Analysis was carried out as previously 
described by Lin & Harnly (2007) in a HPLC model 
LC-20AD (Shimadzu, Kyoto, Japan) equipped 
with quaternary pumps, an on-line degasser, and an 
injection valve (Rheodyne LCC, Rohnert Park, USA) 
with a 20 μL loop. The equipment included, connected 
in series, a photodiode array detector (DAD) SPD-
M20A (Shimadzu) and a mass spectrometer with an 
ion-trap analyzer (MS/MS) Esquire 4000 (Bruker 
Daltonics, Bremem, Germany) and an electron spray 
ESI ionization source. The isoflavones were identified 
according to Lin & Harnly (2007) and quantified using 
external calibration curves for daidzein and genistein 
obtained from Sigma-Aldrich Corp. (St. Louis, MO) 
and glycitein and their β-glucosides (daidzin, genistin 
and glycitin) from LC Labs (Woburn, MA). The 6”-O-
malonyl-β-glucosides were quantified using the curve 
of the corresponding β-glucosides.
MCF-7 and 3T3 cell culture 
 Human breast adenocarcinoma MCF-7, 
obtained from American Type Culture Collection 
(Manassas, USA), and Mouse embryo fibroblast 
3T3, from National Institutes of Health (Bethesda, 
MD), cells were cultured in RPMI-1640 and DMEM 
medium, respectively, supplemented with FSB 10% 
and gentamicin 50 μg.mL-1 in a humidified atmosphere 
containing CO2 5%, according to specification of 
American Type Culture Collection. To assess the 
cell viability, 10 x 103 cells were seeded in 96 well 
plates, and after 24 or 72 h of treatment with different 
concentrations of exudates 3-(4,5-dimethylthiazol-2-
yl)-2,5-diphenyltetrazolium bromide (MTT) reduction, 
neutral red uptaken and nucleic acid content assays 
were performed as described in vitro cell viability 
assays section. For treatments, dry aliquots of exudates 
were solubilized in DMSO 100% and resuspended in 
culture medium (250 to 1000 μg/mL). Aliquots of 100 
μL of these solutions were applied to each well plate 
containing 10 x 103 cells. In all treatments DMSO 
concentration was kept at 0.25%. 
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In vitro cell viability assays
 MTT reduction
 Medium containing isoflavones was removed 
and 0.2 ml of MTT solution (0.5 mg of MTT/mL 
of culture medium) was added to each well. After 
incubation for 4 h at 37 °C, the medium was removed and 
intracellular formazan was released by solubilization in 
0.2 mL of ethanol. Plate was shaken for 5 min on a 
plate shaker prior to measuring the absorbance at 570 
nm (Mosmann, 1983).
 Neutral red uptake
 After 4 h incubation with serum-free medium 
containing 50 μg of neutral red/mL the cells were 
washed quickly with PBS and then 0.1 mL of a solution 
of 1% (v/v) acetic acid: 50% (v/v) ethanol was added to 
each well to extract the dye. After shaking for 10 min 
on a plate shaker the absorbance was read at 540 nm 
(Borenfreund & Borrero, 1984).
 Nucleic acid content
 Cell monolayer was solubilized with 1 mL of 
0.5 M NaOH at 37 oC for 1 h afterwards the absorbance 
of the solution in each well was measured at 260 nm 
and the results expressed as a percentage of the control 
A260 (Cingi et al., 1991).
Cell NO emission
 NO emission was determined using the DAF-2 
fluorescent probe, as described by Hamuro et al. (2002). 
Briefly, the cells submitted to treatments were incubated 
in culture medium containing DAF-2 2.5 μmol.L-1 for 
1h at 37 °C. Culture medium was then collected and the 
fluorescence measured in a F-450 spectrofluorometer 
(Hitachi Instrument Co., Tokyo, Japan) at wavelengths 
of excitation at 488 nm and of emission at 530 nm. 
When indicated, L-NAME 1 mmol.L-1 was added to 
culture medium to prevent NO production by NOS 
(Baylis et al., 1995).
Statistical analysis
 Comparison of means was performed by 
two-way analysis of variance (ANOVA) followed 
by Tukey’s test on Bioestat 5.0 software (Instituto 
de Desenvolvimento Sustentável Mamirauá, Tefé, 
Brazil).
Results and Discussion
Enriching the content of free isoflavones in soybean 
extracts
 Given the well-established pharmaco-
therapeutic activity of free isoflavones, a methodology 
that is simple and efficient for the production of these 
compounds could be a great tool for the development 
of new products of commercial interest. To increase 
the proportion of the aglycone forms of isoflavones, 
soybean seeds were treated with the inducing agent 
sodium nitroprusside (SNP) which was previously 
proven to be very effective in activating the production 
of free isoflavones in cotyledons of soybean seedlings 
(Modolo et al., 2002; Kretzschmar et al., 2009). The 
Figure 1. Chromatographic profile of isoflavones present 
in exudates of soybean seeds after treatment with 10 mM 
sodium nitroprusside (SNP) for 15 h. Extract of (A) untreated 
seeds and treated (B) embrionary axes, (C) cotyledons and 
(d) seeds. The identification of the numbered compounds is 
shown in Table 1.
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efficacy of this treatment was then evaluated in intact 
and non-germinated seeds, as well as in their two 
main components (embrionary axis and cotyledon). 
To perform this evaluation, we compared the results of 
the identification and quantification by HPLC-DAD-
MS of the main isoflavones produced. Figure 1 shows 
the chromatographic profile, and Table 1 shows the 
amounts of isoflavones identified in the exudates when 
intact soybean seeds, embrionary axes or cotyledons 
were treated with 10 mM SNP for 15 h.
 To increase the reliability of the isoflavone 
identification in the samples and to assist in the 
identification of compounds β-conjugated to sugars 
and acids, the peaks detected by HPLC were also 
subjected to tandem mass spectrometry analysis and 
the results were consistent with the previously reported 
fragmentation profile of soybean isoflavones (Cuyckens 
& Claeys, 2004). 
 Figure 1 shows that after treatment with 
SNP, large amounts of isoflavones accumulated in the 
exudates of embrionary axes, cotyledons and seeds. 
The production of these compounds in the control 
was insignificant, thus eliminating the possibility that 
the imbibition of the seeds or their parts with water 
or the mechanical stress (shaking) on the tissues could 
account for the results observed. As shown in Table 1, 
the exudate of embrionary axes presented the best yield 
in terms of total isoflavone production (682±59.7 μg 
of isoflavone per g of dried exudate), when compared 
to that of cotyledons (101±13.0 μg.g-1) and seeds 
(33±2.1 μg.g-1). Additionally, it is remarkable that the 
treatment induced the exudation of a high proportion of 
aglycone forms (daidzein, genistein and glycitein) and 
much lower amounts of the glycosylated- and malonyl-
conjugated forms in all treatments. 
 Among the aglycone forms, daidzein was 
the isoflavone that accumulated at the highest levels 
(approximately 50% of the total aglycone forms) in 
the exudates of the three SNP-treated tissues. The best 
induction of genistein was obtained in the exudates of 
elicited embrionary axes (32±3.5 μg.g fresh exudate-1). 
 The kinetics of isoflavonoid production as a 
function of the elicitation time and SNP concentration 
were evaluated in the exudates of embrionary axes. The 
production of isoflavones increased with incubation 
time (Figure 2A) and SNP concentration (Figure 2B), 
and the largest amount of aglycones was accumulated 
after 20 h of treatment with 200 mmol.L-1of SNP. 
However, with this treatment there is an increase in 
the relative proportion of the conjugated forms, when 
compared with the samples treated with 100 mmol.L-1 
SNP (Figure 2C). As the relative levels of aglycones 
are important for our purpose, elicitation with 100 
mmol.L-1 SNP for 20 h produced the best response in 
terms of aglycone forms.
 As observed with embrionary axes, the 
production of isoflavones was also stimulated as a 
function of SNP concentration and elicitation time in 
cotyledons. When cotyledons were exposed to 100 
mmol.L-1 SNP for 20 h total production of aglycones was 
1,062±12 μg.g-1, where 44% corresponded to daidzein, 
44% to genistein and 12% to glycitein, indicating that 
this treatment can be used for the production of large 
amounts of genistein. It is important to mention that the 
analysis by HPLC and mass spectrometry did not reveal 
the presence of SNP or any degradation product of the 
Table 1. Chromatographic parameters and concentrations of isoflavones identified in exudates of soybean seeds, cotyledons and 
embrionary axes treated with 10 mM sodium nitroprusside for 15 h.
Peak Compound Rt (min)
b λmax (nm)
c
Concentration (μg.g dry weight-1)
Embryo* Cotyledon Seed
1 not identified 13.2 279, 308 n.d. n.d. n.d.
2 daidzin 14.1 260, 300 13±1.1a 8±3.5b 3±0.1c
3 glycitin 15.1 260, 317 15±1.3a 13±3.1a 13±1.3a
4 genistin 16.3 260, 330 10±1.7a 5±0.4b 3±0.1c
5 malonyl-daidzina 17.4 260, 300 60±1.5a 1±0.1b n.d.
6 malonyl-glycitina 18.3 262, 318 45±1.8a 7±0.4b n.d.
7 malonyl-genistina 19.2 261, 330 54±0.8a 6±0.3b n.d.
8 daidzein 20.1 260, 302 243±37a 29±1.3b 8±0.2c
9 glycitein 21.0 260, 319 210±11a 14±2.2b 3±0.1c
10 not identified 21.7 288, 335 _
11 genistein 22.2 262, 330 32±3.5a 18±1.7b 3±0.4c
aConcentrations were estimated using the calibration curves of compounds 2, 3 and 4; n.d.: not detected; Rt: retention time; 
bEluate in the C18 column 
in oven at 32 ºC; cLinear gradient of methanol/5% formic acid. *Embrionary axis. Data are in μg isoflavone per g dry weight extract-1. Samples were 
treated with 10 mM of SNP for 15 h (50 units/10 mL) and the exudates extracted for 20 min with 80% methanol and analyzed by HPLC-DAD-MS. 
Mean±SD of three independent analyses; different letters in the same line are statistically different (p<0.01).
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elicitor agent in the exudates (results not shown). 
 In general, these results show that exudates 
from soybean tissues, mainly those of the embrionary 
axes, demonstrate good yields of aglycones when 
elicited by SNP. 
Influence of soybean exudates in MCF-7 and 3T3 cells 
proliferation
 The antiproliferative activity of isoflavones 
has been well documented in various human tumor cell 
lines (Gacche et al., 2011). As the soybean exudates 
prepared by elicitation with 100 mmol.L-1 SNP for 
20 h produced the best response in terms of aglycone 
forms (Figure 2), their effects on MCF-7 and 3T3 cell 
lines were evaluated and compared with those of non-
elicited extracts. 
 When MCF-7 cells were exposed to exudates 
from elicited embrionary axes (Figure 3A) and cotyledons 
(Figure 3B), a biphasic effect on cell proliferation was 
observed. The major effect in the cell viability was observed 
after treating the cells with 500 μg.mL-1 of exudates from 
embrionary axes and cotyledons, which provoked an 
increase of approximately 20% of proliferation. When 
higher concentrations of those exudates were used, a 
tendency of cell proliferation decrease was observed (Figure 
3A and B). In contrast, MCF-7 cells exposed to exudates of 
non-elicited embrionary axes (Figure 3C) and cotyledons 
(Figure 3D) showed a slight dose-dependent viability 
increase. For both exudates, the maximum observed effect 
in the viability was around 15% after exposure of cells to 
1000 μg.mL-1. These results show that soybean extracts 
enriched in free isoflavones show a biphasic effect on 
proliferation of MCF-7 cells. Differently, extracts from 
non-elicited tissues, which have low concentrations of 
aglycone isoflavones generally displayed a slightly effect 
on cell proliferation. Thus, the difference of action in cell 
viability between non-elicited and elicited exudates may 
be related to the content of free isoflavone aglycones.
 Since MCF-7 cell line expresses estradiol 
receptor (Saceda et al 1988) it could explain the 
higher proliferation capacity of this cell towards lower 
isoflavones concentration. The proliferative effect of 
flavonoids has been attributed to isoflavones, especially 
genistein. This isoflavone is able to bind to the estrogen 
receptor, due to its structural similarity with estradiol, 
and promote cell growth (Wang et al., 1996). Exudates 
from elicited embrionary axes presented higher amounts 
of daidzein and glycitein that have lower estrogenic 
activity while those from elicited cotyledons presented 
higher content of the more potent genistein, what may 
explain their similar effectiveness towards MCF-7 cell 
proliferation. 
 The proliferative action of isoflavones was 
reported in low concentration of estradiol (Casanova 
et al. 1999). However, it has been reported their 
antiproliferative effect on tumor cells at high 
concentrations and this action seems to involve a 
receptor-independent pathway (Gacche et al., 2011). 
In agreement, mouse fibroblast cells (3T3) treated with 
exudates of elicited embrionary axes and cotyledons 
Figure 2. Effect of SNP concentration and time of elicitation 
in the accumulation of free and conjugated isoflavones. 
Embrionary axes were treated with SNP (50 units/10 mL) 
and the isoflavones produced determined in the exudates. 
(A) concentration of aglycones after the indicated periods 
of elicitation with SNP 10 mmol.L-1; (B) concentration of 
aglycones and (C) aglycone and glycosyl-conjugates in 
response to different concentrations of SNP, as indicated, 
after 20 h of elicitation. Mean±SD of three independent 
experiments.
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did not display an expressive changing in their viability 
(results not shown).
Emission of NO by MCF-7 and 3T3 treated with soybean 
exudates
 NO emission induced by treatment with 
soybean exudates enriched in isoflavone aglycones was 
evaluated in MCF-7 and 3T3 cells, since this radical 
is extensively involved in various cellular signals, 
including induction of cell death in tumor lines (Olson 
& Garbán, 2008).
 The modulation of eNOS by estrogen has been 
demonstrated (Hisamoto & Bender, 2005). The eNOS 
is part of a family of enzymes responsible for synthesis 
of NO through the oxidation of L-arginine to L-citrulline 
(Pollock et al., 1991). 
 Figure 4 shows that MCF-7 cells, treated with 
exudates of elicited embrionary axes and cotyledons for 
72 h, displayed emission of NO, which maximum effect 
observed at concentration of 1000 μg.mL-1 exudates (39 
and 25% for embryonic axis-elicited and cotyledons-
elicited exudates, respectively). Interestingly, treatment 
of 3T3 cells with both exudates up to 1000 μg.mL-1 did 
not induce significant changes in the emission of NO after 
72 h. Accordingly, when MCF-7 cells were treated with 
exudates elicited up to a concentration of 1000 μg.mL-1 
and L-NAME, a selective NOS inhibitor (Baylis et al., 
1995), the emission of NO was abolished.
 Several evidences suggest the importance of 
NO in the development and establishment of cancer 
(Bing et al., 2001). However, other authors have reported 
that in high concentration NO presents cytotoxic effect 
and contribute for the reduction of tumor mass (Felly-
Bosco, 1998). Our results are consistent with these 
observations, since at lower NO emission by tumor 
MCF-7 cells coincided with the proliferative effect of 
the exudates. However, when the emission of NO was 
higher, it was observed a tendency of cell proliferation 
inhibition. Our data suggest that the biphasic effect of 
exudates could be, at least in part, due to modulation of 
eNOS activity in MCF-7 cells.
Figure 3. Effects of exudates in natura and elicited with SNP (100 mmol.L-1) on MCF-7 cell viability. A, exudate of elicited 
embrionary axes (EA); B, exudate of elicited cotyledons (CO); C, exudate EA in natura; D, exudate CO in natura. Cells (10 x 
103) were exposed to different exudates concentrations for 72 h. The results are expressed as percentage of control. Cellular 
viability was determined by MTT reduction, neutral red uptake (NR) and DNA content assay. Mean±SD of three independent 
experiments.
Soybean extracts enriched with free isoflavones promote nitric oxide 
synthesis and affect the proliferation of breast adenocarcinoma cells
Pablo G. Ferreira et al.
Rev. Bras. Farmacogn. Braz. J. Pharmacogn. 23(1): Jan./Feb. 201392
 
Figure 4. Nitric oxide (NO) emission by 3T3 and MCF-7 
treated with SNP 100 mmol.L-1 elicited exudates. A, 
embrionary axes (EA) exudates; B, cotyledons (CO) 
exudates. Cells (10 x 103) were exposed to different exudates 
concentrations for 72 h. L-NAME was used at 1 mM, where 
indicated. Mean±SD of three independent experiments. 
 
Conclusion 
 The results presented here demonstrate a 
rapid and easy method to enrich soybean extracts with 
isoflavones in their bioactive forms, the aglycones. 
Still, the enriched extracts show biphasic action 
on the proliferation of breast adenocarcinoma cells 
with proliferative action at lower concentrations and 
inhibitory effect at higher concentrations. It is likely 
that these effects are related to estrogenic activity 
of free isoflavones and their ability to modulate the 
activity of eNOS, and thus NO synthesis. Overall, our 
results suggest that elicitation with SNP could represent 
a simple method to produce exudates enriched in free 
isoflavones and could be exploited to produce functional 
foods or supplements to target health problems.
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